Web-Based Training for Pain Management

November 9, 2026 updated by: Mujde CALIKUSU INCEKAR, Lokman Hekim University

Inadequate management of pain during vaccination may lead to negative vaccination experiences, needle fear, and future vaccine non-adherence in children. This study aims to develop a web-based pain management education program for nurses/midwives and parents to reduce vaccination-related pain in children and evaluate its effectiveness. The study will be conducted using a quasi-experimental pretest-posttest design with a non-randomized control group in two Family Health Centers. Pain will be assessed using the FLACC Pain Scale for children aged 0-3 years and the Wong-Baker FACES Pain Rating Scale for children aged 3 years and older. Pain management practices will be evaluated using an observation form. The information quality of the program will be assessed using DISCERN, and its usability will be evaluated using the System Usability Scale (SUS). Data will be analyzed using appropriate parametric and non-parametric tests. The intervention effect will be evaluated by examining the group-by-time interaction. Statistical significance will be set at p<0.05.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 months to 13 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Nurses/Midwives:

  • Nurses or midwives who administer childhood vaccinations.
  • Nurses or midwives who voluntarily agree to participate in the study.

Parents:

  • Parents of children aged 2 months to 13 years.
  • Parents whose children are scheduled to receive routine vaccinations.
  • Parents who are able to read Turkish.

Exclusion Criteria:

Children:

  • Children with neurological disorders affecting pain perception.
  • Children who have received analgesic medications.
  • Children who are receiving antibiotic treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Web Based Training Group

A web-based, evidence-based pain management education program will be provided separately to nurses/midwives and parents to reduce vaccination-related pain in children. The program includes educational modules consisting of text, visual materials, and videos. The content covers childhood pain, age-specific pain assessment, and evidence-based pharmacological and non-pharmacological pain management approaches. Nurses/midwives will complete approximately 90 minutes of education, while parents will complete approximately 40 minutes of education. Nurses/midwives will complete the program before the post-intervention observation period. Parents will receive the program link and will be asked to complete all modules before vaccination. Module completion will be monitored through the web-based platform.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evidence-Based Pain Management Practices by Nurses/Midwives
Time Frame: At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.

Evidence-based pharmacological and non-pharmacological pain management practices performed by nurses/midwives before, during, and after childhood vaccination will be assessed using the Nurse/Midwife Observation Form. Each practice will be scored as performed (1) or not performed (0). Higher total scores indicate more frequent use of pain management practices.

At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.
Evidence-Based Pain Management Practices by Parents
Time Frame: At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.

Evidence-based pharmacological and non-pharmacological pain management practices performed by parents before, during, and after childhood vaccination will be assessed using the Parent Observation Form. Each practice will be scored as performed (1) or not performed (0). Higher total scores indicate more frequent use of pain management practices.

At baseline and during the post-intervention observation period, before, during, and immediately after vaccination.
Vaccination-Related Pain Scores in Children Aged 0-Under 3 Years
Time Frame: after vaccination implementation

Vaccination-related pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) Pain Scale. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

after vaccination implementation
Vaccination-Related Pain Scores in Children Aged 3 Years and Older
Time Frame: after vaccination implementation

Vaccination-related pain will be assessed using the Wong-Baker FACES Pain Rating Scale. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

after vaccination implementation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality and Reliability of the Web-Based Pain Management Education Program
Time Frame: After development of the web-based pain management education program and before its implementation

The quality and reliability of the web-based pain management education program will be evaluated by 5-7 academic experts using the DISCERN instrument. The instrument consists of 16 items and total scores range from 16 to 80. Higher scores indicate better information quality and reliability.

After development of the web-based pain management education program and before its implementation
Usability of the Web-Based Pain Management Education Program
Time Frame: Immediately after completion of the web-based pain management education program

The usability of the web-based pain management education program will be evaluated using the 10-item System Usability Scale (SUS) by nurses/midwives and parents. Total scores range from 0 to 100, with higher scores indicating better usability. Scores of 65 or above will be considered acceptable usability.

Immediately after completion of the web-based pain management education program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 2, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2027

Study Registration Dates

First Submitted

November 4, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • LHU-MCI-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.